2021
DOI: 10.1016/j.osnem.2021.100123
|View full text |Cite
|
Sign up to set email alerts
|

CoVerifi: A COVID-19 news verification system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
40
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(42 citation statements)
references
References 45 publications
1
40
0
1
Order By: Relevance
“… 13 16 Widespread disinformation, 17 fake news, 18 and the anti-vaccine movement 19 , 20 have caused an increase in self-medication 21 and a general state of misinformation that has been urged to be addressed by governmental institutions. 22 , 23 …”
Section: Introductionmentioning
confidence: 99%
“… 13 16 Widespread disinformation, 17 fake news, 18 and the anti-vaccine movement 19 , 20 have caused an increase in self-medication 21 and a general state of misinformation that has been urged to be addressed by governmental institutions. 22 , 23 …”
Section: Introductionmentioning
confidence: 99%
“…From the results of this work the model accuracy of various algorithms such as k-Nearest neighbourhood and Support Vector Machines proved efficient for the purpose [18]. In another work a COVID-19 news verification system developed based on three tier system developed (CoVerifi), a frontend based on React.js, a backend based on Python Machine Learning services and a database storing [19]. This work presents an application of Machine Learning tools for the prevention of fake news on health.…”
Section: Discussionmentioning
confidence: 84%
“…IFX remains an effective biologic drug for both PsO and PsA patients, but its infusions were difficult to deliver during COVID‐19 pandemic due to both patient‐related (i.e., COVID‐19 phobia or Cabin fever syndrome) and hospital‐related (i.e., infusions room unavailability) causes. 14 Furthermore, during pandemic chronic patients undergoing immunosuppressive drugs globally decreased their compliance 6 due to media disinformation and fake news, 15 discordant position on therapies, COVID‐19, and related outcomes. 3 , 4 , 16 , 17 In line with National Psoriasis Foundation recommendations, 18 The Italian Society of Dermatology (SIDeMaST) suggested not to discontinue biologics in absence of COVID‐19, 19 while in case of COVID‐19, symptomatic or asymptomatic, positions remain still discordant.…”
Section: Discussionmentioning
confidence: 99%